K. Jorgo

Prostate Cancer Survivors Present Long-Term, Residual Systemic Immune Alterations

P. Ágoston, C. Polgár, Z. Takácsi-Nagy, 2022, Cancers.

Normal tissue sparing using different techniques for prostate irradiation.

P. Ágoston, T. Pócza, T. Major, 2020, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

Relationship between biodosimetric parameters and treatment volumes in three types of prostate radiotherapy

P. Ágoston, T. Major, C. Pesznyák, 2021, Scientific Reports.

Comparative dosimetrical analysis of intensity-modulated arc therapy, CyberKnife therapy and image-guided interstitial HDR and LDR brachytherapy of low risk prostate cancer

P. Ágoston, T. Major, C. Polgár, 2021, Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology.

ERG Expression and the Efficacy of Docetaxel Combined with Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer

Lajos, T. Szarvas, A. Maráz, 2018 .

Acute and Late Toxicity after Moderate Hypofractionation with Simultaneous Integrated Boost (SIB) Radiation Therapy for Prostate Cancer. A Single Institution, Prospective Study

P. Ágoston, T. Pócza, T. Major, 2019, Pathology & Oncology Research.

Dosimetric comparison between treatment plans of patients treated with low-dose-rate vs. high-dose-rate interstitial prostate brachytherapy as monotherapy: Initial findings of a randomized clinical trial.

P. Ágoston, T. Major, C. Polgár, 2016, Brachytherapy.

Loose versus stranded seeds in permanent prostate brachytherapy: dosimetric comparison of intraoperative plans.

P. Ágoston, T. Major, C. Polgár, 2014, Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics.

ERG expression can predict the outcome of docetaxel combinedwith androgen deprivation therapy in metastatic hormone-sensitiveprostate cancer.

T. Szarvas, A. Maráz, I. Laczó, 2019, Urologic oncology.

Biological dose summation of intensity-modulated arc therapy and image-guided high-dose-rate interstitial brachytherapy in intermediate- and high-risk prostate cancer

P. Ágoston, T. Major, C. Polgár, 2020, Journal of contemporary brachytherapy.

Transperineal gold marker implantation for image-guided external beam radiotherapy of prostate cancer

P. Ágoston, T. Major, C. Polgár, 2017, Strahlentherapie und Onkologie.

Acute Side Effects After Definitive Stereotactic Body Radiation Therapy (SBRT) for Patients with Clinically Localized Or Locally Advanced Prostate Cancer: a Single Institution Prospective Study

P. Ágoston, T. Major, C. Polgár, 2021, Radiology and oncology.

Alterations of Sexual and Erectile Functions after Brachytherapy for Prostate Cancer Based on Patient-Reported Questionnaires

P. Ágoston, G. Fröhlich, Z. Kocsis, 2024, Prostate Cancer.